EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C86H97Cl3N10O26 |
| Net Charge | 0 |
| Average Mass | 1793.125 |
| Monoisotopic Mass | 1790.56411 |
| SMILES | CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O |
| InChI | InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1 |
| InChIKey | VHFGEBVPHAGQPI-LXKZPTCJSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antibacterial drug A drug used to treat or prevent bacterial infections. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. |
| Application: | antibacterial drug A drug used to treat or prevent bacterial infections. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| oritavancin (CHEBI:82699) has functional parent vancomycin aglycone (CHEBI:47724) |
| oritavancin (CHEBI:82699) has role antibacterial drug (CHEBI:36047) |
| oritavancin (CHEBI:82699) has role antimicrobial agent (CHEBI:33281) |
| oritavancin (CHEBI:82699) is a disaccharide derivative (CHEBI:63353) |
| oritavancin (CHEBI:82699) is a glycopeptide (CHEBI:24396) |
| oritavancin (CHEBI:82699) is a semisynthetic derivative (CHEBI:72588) |
| Incoming Relation(s) |
| oritavancin bisphosphate (CHEBI:83305) has part oritavancin (CHEBI:82699) |
| Synonyms | Source |
|---|---|
| Chlorobiphenyl-chloroeremomycin | KEGG COMPOUND |
| LY333328 | KEGG COMPOUND |
| (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin | ChemIDplus |
| (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C12034 | KEGG COMPOUND |
| Oritavancin | Wikipedia |
| 4678 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:7608605 | Reaxys |
| CAS:171099-57-3 | KEGG COMPOUND |
| CAS:171099-57-3 | ChemIDplus |
| Citations |
|---|